Nuveen’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-143,715
| Closed | -$839K | – | 3462 |
|
|
2025
Q1 | $839K | Sell |
143,715
-225,839
| -61% | -$1.19M | ﹤0.01% | 2713 |
|
|
2024
Q4 | $1.37M | Buy |
369,554
+17,878
| +5% | +$82.5K | ﹤0.01% | 2552 |
|
|
2024
Q3 | $1.97M | Buy |
351,676
+247,668
| +238% | +$1.73M | ﹤0.01% | 2420 |
|
|
2024
Q2 | $876K | Sell |
104,008
-60,476
| -37% | -$645K | ﹤0.01% | 2781 |
|
|
2024
Q1 | $2.38M | Sell |
164,484
-61,547
| -27% | -$1.02M | ﹤0.01% | 2322 |
|
|
2023
Q4 | $4.86M | Buy |
226,031
+866
| +0.4% | +$15.5K | ﹤0.01% | 1993 |
|
|
2023
Q3 | $4.33M | Sell |
225,165
-5,603
| -2% | -$120K | ﹤0.01% | 1938 |
|
|
2023
Q2 | $5.87M | Hold |
230,768
| – | – | ﹤0.01% | 1823 |
|
|
2023
Q1 | $8.34M | Buy |
230,768
+62,647
| +37% | +$2.2M | ﹤0.01% | 1597 |
|
|
2022
Q4 | $6.66M | Buy |
168,121
+35,072
| +26% | +$1.46M | ﹤0.01% | 1749 |
|
|
2022
Q3 | $6.2M | Sell |
133,049
-4,086
| -3% | -$190K | ﹤0.01% | 1765 |
|
|
2022
Q2 | $6.01M | Sell |
137,135
-4,696
| -3% | -$258K | ﹤0.01% | 1824 |
|
|
2022
Q1 | $9.51M | Buy |
141,831
+37,354
| +36% | +$2.69M | ﹤0.01% | 1671 |
|
|
2021
Q4 | $8.49M | Sell |
104,477
-386,072
| -79% | -$38.7M | ﹤0.01% | 1798 |
|
|
2021
Q3 | $57.1M | Sell |
490,549
-49,394
| -9% | -$6.47M | 0.02% | 621 |
|
|
2021
Q2 | $89.5M | Buy |
539,943
+29,047
| +6% | +$4.53M | 0.03% | 506 |
|
|
2021
Q1 | $71.3M | Buy |
510,896
+23,539
| +5% | +$3.84M | 0.02% | 568 |
|
|
2020
Q4 | $84.4M | Buy |
487,357
+84,752
| +21% | +$13.7M | 0.03% | 483 |
|
|
2020
Q3 | $56.1M | Buy |
402,605
+25,198
| +7% | +$3.37M | 0.02% | 543 |
|
|
2020
Q2 | $45.1M | Buy |
377,407
+150,653
| +66% | +$17.9M | 0.02% | 585 |
|
|
2020
Q1 | $22.7M | Sell |
226,754
-50,452
| -18% | -$6.07M | 0.01% | 842 |
|
|
2019
Q4 | $32.6M | Buy |
277,206
+68,069
| +33% | +$6.74M | 0.01% | 892 |
|
|
2019
Q3 | $18M | Sell |
209,137
-204,530
| -49% | -$15.5M | 0.01% | 1197 |
|
|
2019
Q2 | $26.8M | Buy |
+413,667
| New | +$25.8M | 0.01% | 985 |
|
|
2018
Q1 | – | Sell |
-13,888
| Closed | -$959K | – | 1146 |
|
|
2017
Q4 | $959K | Sell |
13,888
-101,864
| -88% | -$8.15M | 0.01% | 758 |
|
|
2017
Q3 | $10.5M | Buy |
115,752
+98,052
| +554% | +$8.39M | 0.07% | 383 |
|
|
2017
Q2 | $1.32M | Buy |
17,700
+853
| +5% | +$68.3K | 0.01% | 691 |
|
|
2017
Q1 | $1.58M | Sell |
16,847
-312
| -2% | -$28.3K | 0.01% | 771 |
|
|
2016
Q4 | $1.25M | Buy |
17,159
+5,544
| +48% | +$475K | 0.01% | 1070 |
|
|
2016
Q3 | $1.21M | Sell |
11,615
-5,328
| -31% | -$481K | 0.01% | 1012 |
|
|
2016
Q2 | $1.25M | Buy |
+16,943
| New | +$1.15M | 0.01% | 939 |
|
Other funds holding NVRO
Nuveen's NVRO Position: Q2 2025 in Review
Nuveen sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 143,715 shares — an estimated $839K sold.
Nuveen first reported a position in NVRO in Q2 2016 and held it in 31 quarters. The position peaked at $89.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Nuveen reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Nuveen sold 143,715 NEVRO CORP. shares in Q2 2025, an estimated $839K.
- Nuveen first reported a position in NEVRO CORP. in Q2 2016 and held it in 31 quarters.
- Nuveen's NEVRO CORP. position peaked at $89.5M in Q2 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.